Option chain shows key data for SinglePoint's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for SinglePoint.

SinglePoint (OTC:SING) Stock, Option Chain

SinglePoint Inc is a renewable and sustainable solution company focused on solar power and indoor air purification. Its primary focus is sustainability by providing an integrated solar energy solution for the customers and clean environment solutions through its air purification business. The company's subsidiary, BOX Pure Air, is engaged in the Indoor Air Quality sector addressing the need for air purification in schools and offices. SinglePoint is exploring future acquisition and growth opportunities in energy storage, electric vehicle charging, solar as a subscription service and additional energy-efficient appliances that enhance sustainability.

Highly Incentivized Scramble For Commercial and Residential Solar As Some Energy Bills Expected To Skyrocket 50% - 200%

Penny Stocks

Emerging Markets

Markets

General

ENPH

FSLR

SING

Of the total new electricity-generating capacity added in the United States last year, 46% was solar power.

Thanks to strong federal policy and technological innovations starting to make solar systems more affordable, the solar industry has enjoyed an average annual growth rate of 33% over the last 22 years.

SinglePoint&#39;s Latest Acquisition May Give Commercial Properties Across Deregulated Markets New Options For Utilizing Solar Energy

Movers & Shakers

Tech

Governments worldwide are finally injecting serious funding into renewable energy, and consumer demand is seemingly shifting toward sustainable and healthier solutions. Now, an industry of hundreds of smaller, local players could see intense competition over the next few years. 

Shining A Light On One Of The Fastest-Growing Companies In Solar Energy Space On The OTCQB

SinglePoint Inc

SINGAPORE AIRLNS SIA ORD by Singapore Airlines Ltd.

Singapore Airlines Ltd

SINGAPORE AIRLNS UNSP/ADR by Singapore Airlines Ltd.

SINGULAR PEOPLE S A by SINGULAR PEOPLE S A

SING TAO NEWS CORP LTD by Sing Tao News Corp., Ltd.

Sing Tao News Corp Ltd

SINGAMAS CONTAINER by Singamas Container Holdings Ltd.

Singamas Container Holdings Ltd

SINGAPORE EXCH UNSP/ADR by Singapore Exchange Ltd.

Singapore Exchange Ltd

SINGAPORE EXCHANGE LTD by Singapore Exchange Ltd.

SINGAPORE LD GRP U/ADR by SINGAPORE LD GROUP LTD

Singapore Land Group Ltd

SINGAPORE LD GROUP LTD by SINGAPORE LD GROUP LTD

SINGAPORE POST LTD by Singapore Post, Ltd.

Singapore Post Ltd

SINGAPORE POST UNSP/ADR by Singapore Post, Ltd.

SINGAPORE TEC EN UNSP/ADR by Singapore Technologies Engineering Ltd.

Singapore Technologies Engineering Ltd

SINGAPORE TECH ENG LTD by Singapore Technologies Engineering Ltd.

SINGAPORE TELECM ORD 1000 by Singapore Telecommunications Ltd.

Singapore Telecommunications Ltd

SINGAPORE TELECOM S/ADR by Singapore Telecommunications Ltd.

Singular Genomics Systems, Inc. - Common Stock

Singular Genomics Systems Inc

Singularity Future Technology Ltd. - Common Stock

Singularity Future Technology Ltd

SingularityDAO

SingularityNET

SINGULUS TEC UNSP/ADR by Singulus Technologies AG

Singulus Technologies AG

SINGULUS TECHS AG by Singulus Technologies AG

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

BJDX

SMST

LIFW

SMCX

LIFWW

<p><strong>Numinus Wellness Inc.</strong> (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/NUMIF#OTCQX">NUMIF</a>), a leader in <a href="https://www.benzinga.com/topic/psychedelic-assisted-therapies">psychedelic-assisted mental health care</a>, has <a href="https://www.investors.numinus.com/news/news-details/2024/Numinus-Wellness-Announces-Sale-of-Clinics-and-Unique-Data-Partnership-to-Increase-Access-to-Mental-Health-Care/default.aspx">announced</a> a definitive agreement with <strong>Stella</strong>, an interventional psychiatry practice, to sell its five wellness clinics in Utah for a total of <strong>$3.53 million</strong>. The transaction, expected to close by November 30, marks a strategic shift for Numinus, as it pivots towards <a href="https://www.benzinga.com/markets/cannabis/24/09/40845569/mdma-therapy-for-ptsd-faces-fda-delay-are-there-other-ways-forward">developing technology-driven solutions</a> aimed at enhancing the efficiency of mental health care providers.</p>
<h3 class="wp-block-heading"><strong>Tech Partnership To Redefine Mental Health Clinics</strong></h3>
<p>In addition to the sale, Numinus and Stella will collaborate on a data-sharing initiative to launch an innovative clinic management platform. By leveraging operational insights from Stella's 12 clinics, Numinus plans to develop a software solution designed to streamline clinic operations, enhance patient outcomes and support insurance reimbursement processes.</p>
<p>"This transaction marks an exciting new chapter in Numinus' strategy to reshape behavioral health care," said <strong>Payton Nyquvest</strong>, founder and CEO of Numinus. "Leveraging our expertise in patient care, we're now accelerating our mission by focusing on cutting-edge technology solutions. Through our partnership with Stella, we gain unprecedented access to operational data that will enable us to develop a SaaS (software as a service) solution to redefine how clinics operate."</p>
<h3 class="wp-block-heading"><strong>Stella Takes Over Utah Operations</strong></h3>
<p>Stella, known for its focus on treating PTSD, anxiety and depression through biological modalities, will assume control of Numinus' Utah clinics. The acquisition includes an upfront payment of <strong>$2.08 million</strong>, followed by <strong>$750,000</strong> in installments throughout 2025, and up to <strong>$700,000</strong> in deferred compensation.</p>
<p>"Stella's expansion into Utah brings additional life-changing treatments to the community while supporting Numinus' broader tech initiatives," stated <strong>Michael Gershenzon</strong>, co-founder and CEO of Stella. "This partnership reflects our commitment to improving behavioral health systems and processes, ultimately enhancing patient care."</p>
<h3 class="wp-block-heading"><strong>An Asset-Light Business Model With Enhanced Focus</strong></h3>
<p>With the sale of its clinics, Numinus will shift towards an asset-light model, focusing on its business units like Cedar Clinical Research and the Numinus Network. The strategy aims to integrate clinical research, practitioner training and technology solutions, supporting mental health providers worldwide. The move is part of a broader effort to ease the operational burdens faced by healthcare professionals, particularly as demand for treatments like <a href="https://www.benzinga.com/topic/ketamine-therapy">ketamine</a> and Spravato continues to rise.</p>
<p>"Stella will bolster our clinical solutions offering, leveraging their deep expertise in patient care," Nyquvest added. "We expect strong demand for our Numinus Network Solutions as mental health practitioners navigate growing requests for care."</p>
<p><em>Cover image made with AI</em></p>


Cannabis

News

Psychedelics

NUMIF

Numinus Wellness Sells US Clinics, Partners With Stella For Tech-Driven Mental Health Solutions

<p>President-elect <strong>Donald Trump</strong> has chosen former Representative <strong>Doug Collins </strong>(R-GA) to lead the <a href="https://www.benzinga.com/cannabis">U.S. Department of Veterans Affairs (VA). </a></p>
<p>The decision has sparked discussions about how the agency might handle medical cannabis issues, given his inconsistent track record on the issue, as <a href="https://www.marijuanamoment.net/trumps-pick-to-lead-va-voted-against-letting-agency-doctors-recommend-medical-marijuana-to-veterans-before-he-adopted-a-pro-reform-position/">reported</a> Marijuana Moment.</p>
<h3 class="wp-block-heading"><strong>Collins' Record On Cannabis</strong></h3>
<p>During his time in Congress, Collins opposed efforts to expand access to medical cannabis for veterans. Between 2014 and 2016, he voted against three proposals that would have allowed VA doctors to recommend cannabis to their patients.</p>
<p><strong>See Also: <a href="https://www.benzinga.com/markets/cannabis/24/11/42018478/trumps-cabinet-choices-will-his-administration-support-or-restrict-cannabis">Trump&#8217;s Cabinet Choices: Will His Administration Support Or Restrict Cannabis?</a></strong></p>
<p>Collins' views began to shift in 2019. He supported the STATES Act, which would protect state marijuana programs from federal interference, and co-signed a letter with Rep. <strong>Matt Gaetz</strong> (R-FL), urging Congress to take action on cannabis policy. </p>
<p>"We believe this Committee and this Congress must act to clarify the rights and responsibilities, relative to cannabis, of individuals, physicians, businesses, medical patients, and law enforcement officials," they wrote.</p>
<p>Later that year, Collins backed a bipartisan bill to protect banks that serve marijuana businesses in states where it is legal. However, he did not take part in a 2020 vote on federal cannabis legalization.</p>
<h3 class="wp-block-heading"><strong>Collins' Stance On Psychedelics</strong></h3>
<p>When it comes to psychedelics, there isn't much known about Collins's stance. However, his shifting views on cannabis policy hint that he could be open to exploring different approaches.</p>
<h3 class="wp-block-heading"><strong>Cannabis At The VA</strong></h3>
<p>VA policy has long prohibited its doctors from recommending cannabis, citing marijuana's classification as a Schedule I controlled substance under federal law. This stance has remained consistent across both Republican and Democratic administrations, despite growing support for change in Congress.</p>
<p>Recent efforts to address this issue include a Senate Appropriations Committee request for the VA to explore cannabis as an alternative to opioids. Lawmakers have also introduced measures that would allow VA doctors to recommend cannabis in states where it is legal. These efforts have gained bipartisan support, but none have yet become law.</p>
<p>Veterans service organizations have pushed for further reforms, including expanded research into the potential benefits of cannabis. Last year, a Senate committee approved a bill to study cannabis for veterans with certain medical conditions, but it failed to advance to a floor vote.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/general/health-care/24/11/42017583/trumps-go-wild-on-health-plan-puts-rfk-jr-in-charge-what-it-means-for-cannabis-and-psychedelics-reform"><strong>Trump&#8217;s &#8216;Go Wild On Health&#8217; Plan Puts RFK Jr. In Charge: What It Means For Cannabis And Psychedelics Reform</strong></a></li>
</ul>
<p><em>Cover image made with AI.</em></p>


Government

Politics

Trump-Appointed Doug Collins To Lead VA: What's Next For Cannabis and Psychedelics In Veterans' Healthcare?

<p>Chardan Capital  analyst Daniil Gataulin   maintains Clearside Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSD#NASDAQ">CLSD</a>) with a Buy and maintains $6 price target.</p>


Price Target

Analyst Ratings

CLSD

Chardan Capital Maintains Buy on Clearside Biomedical, Maintains $6 Price Target

<p>Chardan Capital  analyst Daniil Gataulin   maintains Cognition Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGTX#NASDAQ">CGTX</a>) with a Buy and maintains $11 price target.</p>


CGTX

Chardan Capital Maintains Buy on Cognition Therapeutics, Maintains $11 Price Target

<p>Telsey Advisory Group  analyst Cristina Fernandez   maintains Williams-Sonoma (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSM#NYSE">WSM</a>) with a Outperform and maintains $165 price target.</p>


Telsey Advisory Group Maintains Outperform on Williams-Sonoma, Maintains $165 Price Target

<p><i>– Approval based on positive data from the AUGMENT-101 clinical trial, in which Revuforj delivered robust and durable rates of remission in R/R acute leukemia patients with a KMT2A translocation –</i></p>
<p><i>– Syndax to host conference call today at 6:00 p.m. ET –</i></p>
<p>WALTHAM, Mass., Nov. 15, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDX#NASDAQ">SNDX</a>) today announced that the U.S. Food and Drug Administration (FDA) has approved Revuforj&#xAE; (revumenib) as the first and only menin inhibitor for the treatment of relapsed or refractory (R/R) acute leukemia with a lysine methyltransferase 2A gene (KMT2A) translocation in adult and pediatric patients one year and older. The FDA previously granted Breakthrough Therapy and Fast Track designations as well as Priority Review for Revuforj. The New Drug Application (NDA) received approval through the FDA's Real Time Oncology Review (RTOR) program.</p>


Biotech

SNDX

Syndax Announces FDA Approval Of Revuforj, The First And Only Menin Inhibitor To Treat Adult And Pediatric Patients With Relapsed Or Refractory Acute Leukemia With A KMT2A Translocation

<p>IT Tech Packaging (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ITP#AMEX">ITP</a>) reported quarterly losses of $(0.20) per share. This is unchanged from the same period last year.  The company reported $25.08 million in sales this quarter. This is a 59.03 percent increase over sales of $15.77 million the same period last year.</p>


Earnings

IT Tech Packaging Q3 EPS $(0.20), Same YoY, Sales $25.08M Up From $15.77M YoY

<p>RumbleOn, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBL#NASDAQ">RMBL</a>) (the "Company" or "RumbleOn") announced today that the close of business (4:00 p.m. Central Time) on November 25, 2024 has been fixed as the record date (the "Record Date") for its previously announced proposed $10.0 million registered equity rights offering (the "Rights Offering"), which was announced in a Form 8-K filed with the U.S. Securities and Exchange Commission ("SEC") on November 12, 2024.</p>


Offerings

RMBL

RumbleOn Announces That The Close Of Business On November 25, 2024 Has Been Fixed As The Record Date For Its Previously Announced Proposed $10M Registered Equity Rights Offering

<p>Telsey Advisory Group  analyst Dana Telsey   maintains European Wax Center (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWCZ#NASDAQ">EWCZ</a>) with a Outperform and maintains $8 price target.</p>


EWCZ

Telsey Advisory Group Maintains Outperform on European Wax Center, Maintains $8 Price Target

<p><a href="https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20241115-1475367/1475367_4rcm.pdf" title="https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20241115-1475367/1475367_4rcm.pdf">https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20241115-1475367/1475367_4rcm.pdf</a></p>


FOUR

Shift4 Payments Will Replace R1 RCM In The S&P Midcap 400 Effective Prior To The Opening Of Trading On Wednesday, November 20

<p>China Green Agriculture, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CGA#NYSE">CGA</a>) has changed its name to Enlightify Inc., effective November 25, 2024. Its ticker symbol will change to ENFY effective November 25, 2024, and it is expected to begin trading under that symbol on November 26, 2024. The Company mainly produces and distributes humic acid-based compound fertilizers, other varieties of compound fertilizers and agricultural products through its subsidiaries in China.</p>


China Green Agriculture Changes Name to Enlightify Inc.; Its Ticker Symbol Will Change To 'ENFY' Effective November 25, 2024, And It Is Expected To Begin Trading Under That Symbol On November 26, 2024

<p>Alpha Cognition (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACOG#NASDAQ">ACOG</a>) reported quarterly losses of $(0.31) per share. This is a 63.1 percent increase over losses of $(0.84) per share from the same period last year.</p>


ACOG

Alpha Cognition Q2 EPS $(0.31) Up From $(0.84) YoY

<p>D. Boral Capital  analyst Jason Kolbert   maintains NRX Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRXP#NASDAQ">NRXP</a>) with a Buy and maintains $31 price target.</p>


NRXP

D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $31 Price Target

<p>D. Boral Capital  analyst Jason Kolbert   maintains VolitionRX (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VNRX#AMEX">VNRX</a>) with a Buy and maintains $5 price target.</p>


VNRX

D. Boral Capital Maintains Buy on VolitionRX, Maintains $5 Price Target

Singlepoint Inc (SING) is near the bottom in its industry group according to InvestorsObserver. SING gets an overall rating of 0. That means it scores higher than 0 percent of stocks. Singlepoint Inc gets a 0 rank in the Solar industry. Solar is number 136 out of 148 industries. SING has an Overall Score of 0. Find out wha

Is Singlepoint Inc (SING) Stock at the Top of the Solar Industry?

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><a href="https://investorplace.com/industries/energy/renewable-energy/solar/">Solar stocks</a> continue to present intriguing opportunities for investors looking for growth potential. This February edition highlights three companies that stand out for their innovative approaches and strategic moves in the market. Each of these companies has demonstrated significant potential despite the challenges and volatility inherent in the solar industry.</p>



<p>The recent headwinds battering the solar industry may be disappointing for those who think in the short-term. However, looking further ahead, we can agree that solar will become a crucial part of the world&rsquo;s transition to a carbon-free model.</p>



<p>So, with this growth prospect in mind, here are three solar stocks that could multiply investments and become multibaggers.</p>



<h2>Enphase Energy (ENPH)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/07/enph1600-300x169.png" alt="Smartphone with logo of American company company Enphase Energy Inc. (ENPH) on screen in front of business website. Focus on left of phone display. Unmodified photo."><div>Source: T. Schneider / Shutterstock.com</div></div><p><strong>Enphase Energy</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/enph-stock-quote/"><strong>ENPH</strong></a></span>) is known for its microinverters, energy storage systems and energy management technology.</p>



<p>The company remains a significant player in the solar energy sector despite facing challenges such as weaker-than-expected demand in Europe. Analysts appreciate it catering primarily to the rooftop solar market with a fully integrated solar-plus-storage solution.</p>



<p>The company has numerous forks in the fire for future growth. This includes starting battery manufacturing in the U.S. to enhance IRA incentives and support its bottom line. For Q4, management expects revenue in the <a href="https://seekingalpha.com/article/4653329-enphase-stock-still-long-term-opportunity-amid-near-term-weakness">$300 to $350 million range</a>, with a gross margin above 40%, even excluding IRA benefits.</p>



<p>The company&rsquo;s stock price has fallen 39.70% over the past year amid global headwinds that have battered the entire industry. This implies a substantial upside from its current stock price and thus, is undervalued.</p>



<h2>JinkoSolar (JKS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/06/jks-stock-300x169.jpg" alt="The JinkoSolar logo displayed on a plain white wall."><div>Source: Lutsenko_Oleksandr / Shutterstock.com</div></div><p><strong>JinkoSolar</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/jks-stock-quote/"><strong>JKS</strong></a></span>) is widespread in key markets worldwide. The company reported Q3 2023 earnings with a <a href="https://www.nasdaq.com/press-release/four-bright-solar-stocks-heading-into-2024-2023-11-13">63% year-over-year revenue increase</a> and a notable improvement in gross profit. JKS stock&rsquo;s diversified customer base spans various regions, including China, the United States, Japan, Germany and many others&#8203;.</p>



<p>JKS is gearing up for a good year in FY2024 with its N-type 66-cell solar panels deploying in African markets. These panels, <a href="https://seekingalpha.com/article/4664179-jinkosolar-green-growth-at-a-bargain-price">boasting 600W power output</a> and 22.72% efficiency, represent strong technological progress for the company.&nbsp;</p>



<p>Some analysts are very bullish on JKS. The company&rsquo;s P/E ratio stands <a href="https://seekingalpha.com/article/4664179-jinkosolar-green-growth-at-a-bargain-price">significantly below</a> the <strong>S&amp;P 500</strong> average for the solar sector. Assuming a conservative discount from the U.S. average P/E ratio due to unique risks, JKS still appears significantly undervalued. Its long-term valuation estimate places the stock price between $90-$100.</p>



<h2>SinglePoint (SING)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/12/solar-stocks-1600-300x169.jpg" alt="rows of solar panels, representing solar stocks"><div>Source: Love Silhouette / Shutterstock.com</div></div><p><strong>SinglePoint</strong> (CBOE:<span><a href="https://investorplace.com/stock-quotes/sing-stock-quote/"><strong>SING</strong></a></span>) has completed the acquisition of the remaining interests in Boston Solar.&nbsp; This move and its <a href="https://finance.yahoo.com/news/spotlight-singlepoint-ceo-explains-hawk-131500600.html">recent uplisting</a> to the CBOE marketplace have strengthened SinglePoint&rsquo;s balance sheet and credibility.</p>



<p>The CEO of SinglePoint has <a href="https://finance.yahoo.com/news/spotlight-singlepoint-ceo-explains-hawk-131500600.html">expressed confidence</a> in the company&rsquo;s trajectory, citing over $30 million in trailing 12-month revenues as a strong foundation for future growth. The focus for 2024 includes continuing to acquire accretive assets.</p>



<p>SING could be one of those multibaggers in the making due to its very low valuation. Its market cap was just 2.75 million and its share price hovers around the $0.34 mark.</p>



<p>The uplisting to the CBOE BZX market and the funds raised could be highly accretive for early investors. It gives the company the required liquidity to launch various projects, which is a huge advantage over its peers.</p>



<p><em>On the date of publication, Matthew Farley did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed are those of the writer, subject to the InvestorPlace.com <a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a></em>.</p>
<div><p>Matthew started writing coverage of the financial markets during the crypto boom of 2017 and was also a team member of several fintech startups. He then started writing about Australian and U.S. equities for various publications. His work has appeared in MarketBeat, FXStreet, Cryptoslate, Seeking Alpha, and the New Scientist magazine, among others.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/07/venture-capitalist-predicts-this-chatgpt-announcement-will-shock-the-world/?cid=MKT744191&amp;eid=MKT793994">ChatGPT IPO Could Shock the World, Make This Move Before the Announcement</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/02/wall-street-legend-issues-urgent-ai-code-red/?cid=MKT781156&amp;eid=MKT793989">&ldquo;America&rsquo;s Top Trader&rdquo; Issues A.I. Code Red: Act Now or Miss Out</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793998">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/02/3-solar-stocks-that-could-be-multibaggers-in-the-making-february-edition/">3 Solar Stocks That Could Be Multibaggers in the Making: February Edition</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

3 Solar Stocks That Could Be Multibaggers in the Making: February Edition

A rating of 0 puts Singlepoint Inc (SING) near the top of the Technology sector according to InvestorsObserver.Singlepoint Inc's score of 0 means that it ranks higher than 0% of stocks in the sector. In addition, its overall score of 0 ranks it higher than 0% of all stocks. SING has an Overall Score of 0. Find out what thi

Will Singlepoint Inc (SING) Stay at the Bottom of the Technology Sector?

Singlepoint Inc (SING) is near the bottom in its industry group according to InvestorsObserver. SING gets an overall rating of 0. That means it scores higher than 0 percent of stocks. Singlepoint Inc gets a 0 rank in the Solar industry. Solar is number 131 out of 148 industries. SING has an Overall Score of 0. Find out wha

Singlepoint Inc (SING) stock is lower by -99.91% over the last 12 months. InvestorsObserver's proprietary ranking system, gives SING stock a score of  0 out of a possible 100. That rank is chiefly influenced by a short-term technical score of 0. SING's rank also includes a long-term technical score of 0.  SING has an Overa

Singlepoint Inc (SING) Stock Is Down -10.53% This Week: Buy, Hold, or Sell?

SinglePoint acquires remaining interests in Boston Solar

Singlepoint Inc (SING) stock is lower by -99.92% over the last 12 months. InvestorsObserverâ€&#x2122;s proprietary ranking system, gives SING stock a score of  0 out of a possible 100. That rank is primarily influenced by a short-term technical score of 0. SING's rank also includes a long-term technical score of 0.  SING has an Ove

Singlepoint Inc (SING) Stock  Falls -10.34% This Week: Is It a Good Pick?

Singlepoint Inc (SING) is near the bottom in its industry group according to InvestorsObserver. SING gets an overall rating of 0. That means it scores higher than 0 percent of stocks. Singlepoint Inc gets a 0 rank in the Solar industry. Solar is number 133 out of 148 industries. SING has an Overall Score of 0. Find out wha

An update from SinglePoint (SING) is now available. The Company has announced the release of its Annual Report, making headlines with its latest fi...

SinglePoint Annual Report: Transparency and Regulatory Insights

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><a href="https://www.iea.org/news/massive-expansion-of-renewable-power-opens-door-to-achieving-global-tripling-goal-set-at-cop28">The <em>IEA&rsquo;s Renewables</em> 2023 report</a> highlights the rapid expansion of renewable power capacity worldwide, which grew by 50% in 2023, led by China, Europe, the United States, and Brazil. Solar PV and wind accounted for most of the growth. This has led to my list of <a href="https://investorplace.com/industries/energy/renewable-energy/solar/">solar stocks</a> to buy.</p>



<p>Furthermore, the <em>IEA</em> notes that solar PV costs have declined significantly, while the wind industry faces supply chain disruptions and higher costs. Progress on renewable-based hydrogen projects has been slower than expected.&nbsp;</p>



<p>Given that the valuations of many of these solar stocks to buy remain reasonable in my opinion, it then makes sense for investors to start considering them as potential investments. Some of these firms are so attractively priced that they could lead to seven-figure gains for lucky investors.</p>



<p>Investors considering solar or other renewable <a href="https://investorplace.com/industries/energy/">energy stocks</a> should carefully evaluate individual companies&rsquo; financial health, growth prospects, and competitive positioning within the industry. But with that said, here are seven solar stocks for investors to consider buying.</p>



<h2>First Solar (FSLR)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/10/fslr1600-300x169.png" alt="Person holding smartphone with logo of US renewable energy company First Solar Inc. (FSLR) on screen in front of website. Focus on phone display. Unmodified photo."><div>Source: T. Schneider / Shutterstock.com</div></div><p><strong>First Solar Inc. </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/fslr-stock-quote/"><strong>FSLR</strong></a>) is renowned for its robust performance in the solar industry. Recent strategic growth and positive adjustments in analyst price targets suggest a promising future for the company.</p>



<p>The <a href="https://stockanalysis.com/stocks/fslr/forecast/">average analyst price target</a> is $235.46, with predictions ranging from $157.56 to as high as $356. This indicates a potential increase of about 19.17% from its current price. nalysts generally rate First Solar as a &ldquo;Strong Buy,&rdquo; suggesting they anticipate the stock will perform very well in the near future.</p>



<p>Strategically, First Solar is poised for continued growth, with revenue forecasts showing significant increases over the next few years. Analysts project a growth in revenue from $4.5 billion in 2024 to potentially $6.7 billion by 2026, which would mark a substantial increase.</p>



<p>The company&rsquo;s market cap of 21 billion makes it a sizable company, but this too may give investors some sense of assurance and also makes it less of a speculative bet compared with other firms on this list.</p>



<h2>Enphase Energy (ENPH)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/07/enph1600-300x169.png" alt="Smartphone with logo of American company company Enphase Energy Inc. (ENPH) on screen in front of business website. Focus on left of phone display. Unmodified photo."><div>Source: T. Schneider / Shutterstock.com</div></div><p><strong>Enphase Energy Inc.</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/enph-stock-quote/"><strong>ENPH</strong></a>) has made a strong impression with its micro inverter technology, crucial for converting solar power for home use. Enphase has expanded its market presence in Europe and Australia.</p>



<p>For the first quarter of 2024, <a href="https://www.gurufocus.com/news/2416371/enphase-energy-inc-enph-q1-2024-earnings-call-transcript-highlights-navigating-market-dynamics-with-strategic-foresight">Enphase Energy reported revenue</a> of $263.3 million with a non-GAAP net income of $48 million and a GAAP net loss of $16.1 million. The non-GAAP EPS was $0.35, and the GAAP loss per share was $0.12.&nbsp;</p>



<p>The company generated $41.8 million in free cash flow. Enphase shipped approximately 1.4 million microinverters and 75.5 megawatt hours of batteries. Revenue for Q2 is expected to be between $290 million and $330 million with a GAAP gross margin forecasted between 42% to 45%.</p>



<p>All of these are strong numbers and many of them are improvements on a year-over-year basis. ENPH&rsquo;s valuation is also slightly better than FSLR&rsquo;s by market cap at 15 billion, thus giving it more upside.</p>



<h2>JinkoSolar (JKS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/10/solar_panels-300x169.jpg" alt="A photo of two men installing a solar panel. Solar stocks"><div>Source: Shutterstock</div></div><p><strong>JinkoSolar</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/jks-stock-quote/"><strong>JKS</strong></a>) stands out with its significant global presence and impressive shipment volumes. I feel that a sizable investment into JKS could lead to to a seven-figure sum.</p>



<p>JinkoSolar r<a href="https://www.investing.com/news/stock-market-news/earnings-call-jinkosolar-q1-2024-results-show-soaring-module-shipments-93CH-3404716">eported its first quarter financial results</a> for 2024 with total revenues reaching RMB 23.04 billion (approximately U.S.$3.19 billion). This marked a slight decrease of 1.2% from the same period in the previous year. The company also experienced a decrease in gross profit to RMB 2.74 billion (U.S.$378.8 million) and an operating loss of RMB 339.6 million (U.S.$47.0 million). This is where I believe that JKS could be an undervalued pick.</p>



<p>Despite these financial pressures, JinkoSolar&rsquo;s module shipments showed significant growth, increasing by 53.3% year-over-year to nearly 20 gigawatts. The company remains optimistic about the global demand for photovoltaic (PV) modules, projecting an increase of 25% to 30% in 2024. They expect module shipments for the second quarter to be between 24 and 26 gigawatts, with full-year shipments anticipated to reach between 100 and 110 gigawatts.</p>



<p>With a market cap of just around 1.3 billion, it remains one of those small-cap solar stocks to buy for a potentially great pay day ahead.</p>



<h2>Shoals Technologies (SHLS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/07/shutterstock_1723842919-300x169.jpg" alt="Solar penny stocks: a close up of a solar cell farm. solar stocks"><div>Source: Fit Ztudio / Shutterstock</div></div><p><strong>Shoals Technologies </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/shls-stock-quote/"><strong>SHLS</strong></a>) provides comprehensive electrical balance system solutions for solar power systems.&nbsp;</p>



<p>For the <a href="https://www.globenewswire.com/news-release/2024/05/07/2877222/0/en/Shoals-Technologies-Group-Inc-Reports-Financial-Results-for-First-Quarter-2024.html">first quarter of 2024</a>, the company reported a decline in net revenue by 14% to $90.8 million, and a decrease in gross profit to $36.5 million from the previous year.<br><br>Looking ahead to the rest of 2024, Shoals Technologies has provided a revenue forecast ranging from $440 million to $490 million, with adjusted EBITDA expected to be between $130 million and $150 million. These projections indicate a cautious but optimistic outlook as the company aims to manage its operational challenges and capitalize on market opportunities. </p>



<p>The guidance suggests that while the first half of the year may be weaker, there are expectations for a stronger performance towards the end of the year.</p>



<p>I think that that SHLS could be a good pick for investors who want to diversify their solar portfolio holdings away from direct players and into the realm of companies that provide the &ldquo;picks and shovels&rdquo; that help the solar energy thrive, which could have great upside.</p>



<h2>Sunrun (RUN)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/08/sunrun-run-1600-300x169.jpg" alt="The Sunrun (RUN) logo is displayed on a smartphone screen in front of an American flag."><div>Source: IgorGolovniov / Shutterstock.com</div></div><p><strong>Sunrun</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/run-stock-quote/"><strong>RUN</strong></a>) has faced market challenges but remains a leader in its segment. The company has demonstrated adaptability with significant growth in its installed storage capacity and revenue.</p>



<p>Last quarter, the <a href="https://investors.sunrun.com/news-events/press-releases/detail/312/sunrun-reports-first-quarter-2024-financial-results">company&rsquo;s total revenue</a> was $458.2 million, which represented a 22% decrease from the first quarter of the previous year. Despite this, there was a significant growth in customer agreements and incentives revenue, which increased by 31% to $323 million.&nbsp;</p>



<p>For the full year of 2024, Sunrun expects a challenging outlook for solar energy capacity, projecting a decline of 15% to flat growth. However, the company anticipates strong growth in storage capacity, expecting to install between 800 megawatt hours to 1 gigawatt hour, representing a growth of 40% to 75% year over year.&nbsp;</p>



<p>Sunrun also plans to achieve positive cash generation from the fourth quarter of 2023 through the fourth quarter of 2024, with an annualized run rate of $200 million to $500 million&#8203;.</p>



<p>It may not be possible for investors to get a seven-figure sum without also risking a proportionate amount in capital, and I think RUN offers that attractive blend of risk and reward.</p>



<h2>Maxeon Solar Technologies (MAXN)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/03/shoals_shls_solar_1600-300x169.png" alt="solar and wind power in coastal saline and alkaline land, develop shoals background representing solar stocks."><div>Source: chuyuss / Shutterstock.com</div></div><p><strong>Maxeon Solar Technologies </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/maxn-stock-quote/"><strong>MAXN</strong></a>) has carved out its niche with innovative solar panel technologies and a strong patent portfolio. The company&rsquo;s global reach and significant agreements in various markets position it well for future revenue growth and market expansion.</p>



<p>The company <a href="https://mediaroom.maxeon.com/2024-02-14-Maxeon-Solar-Technologies-Announces-Completion-of-First-Customer-Installation-with-Next-Generation-Maxeon-IBC-Panels">has set a strong performance</a> standard with the release of its Maxeon 7 panels, which feature an industry-leading efficiency rate of 24.9%. These panels have been recognized for their superior performance and reliability.</p>



<p>Looking forward, Maxeon expects to see a positive impact from its strategic initiatives and its focus on innovative, high-efficiency products. The company is also expanding its market reach, with Maxeon 7 panels soon to be commercially available across various regions, targeting a broader deployment in the third quarter of 2024.</p>



<p>With MAXN being a penny stock trading at $2.95 at the time of writing, it provides investors exposure to the extreme risks required in order to make a potentially seven-figure windfall from a sizable investment.</p>



<h2>SinglePoint (SING)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/10/solar-1-300x169.jpg" alt="Clean energy stocks: Rows of solar panels are lined up around a center aisle."><div>Source: Shutterstock</div></div><p><strong>SinglePoint</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/sing-stock-quote/"><strong>SING</strong></a>) has diversified its offerings by venturing into air purification and energy services, alongside its core solar installations.<br><br>In 2024, the company is <a href="https://singlepoint.com/news/">actively leveraging its capabilities</a> in solar energy through its subsidiary, <strong>Boston Solar</strong>, which continues to lead projects that enhance renewable energy solutions across various sectors.&nbsp;</p>



<p>Financially, SinglePoint has been focusing on achieving operational profitability and continued revenue growth. Looking ahead, SinglePoint aims to maintain its growth trajectory by further enhancing its solar capabilities and expanding its service offerings. This includes continuing to build partnerships and undertaking new projects that not only increase the company&rsquo;s market reach.</p>



<p>However it should be noted that SING&rsquo;s stock price has cratered over 88% year-to-date, but this extreme risk to reward profile may be appealing for those with strong risk tolerances. Over the last five days, its stock price has increased 14.21%, which indicates there is still some strong interest left in the stock since it may have fallen to oversold levels.<br></p>



<p><em>On the date of publication, Matthew Farley did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed are those of the writer, subject to the</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/"><em> </em>InvestorPlace.com Publishing Guidelines</a>.</p>
<div><p>Matthew started writing coverage of the financial markets during the crypto boom of 2017 and was also a team member of several fintech startups. He then started writing about Australian and U.S. equities for various publications. His work has appeared in MarketBeat, FXStreet, Cryptoslate, Seeking Alpha, and the New Scientist magazine, among others.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/05/7-solar-stocks-that-could-be-millionaire-makers-may-edition/">7 Solar Stocks That Could Be Millionaire-Makers: May Edition</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

7 Solar Stocks That Could Be Millionaire-Makers: May Edition

MAXN

SHLS

4 Solar Stocks Poised for Growth In 2024

Bright Horizons: Top Solar Stocks for 2024

4 Solar Stocks to Put on your watchlist for 2024

Commodities

Small Cap

Press Releases

SinglePoint subsidiary Boston Solar Welcomes New President Michael Morlino; Provides Insight to 2024

SinglePoint Inc. announces receipt of Cboe BZX Minimum Bid Price Notification and Confirms Commitment to Compliance with Exchange Requirements

Planet MicroCap Review Magazine for Winter/Spring 2024 Now Online

Boston Solar Commercial Division Announces 25+ Solar System Partnership with Local Non-Profit Housing Developer to Reduce Local Community's Carbon Footprint

SinglePoint Inc. Provides Corporate Update on Boston Solar Commercial Solar Division Accelerating to Near-Term Operational Profitability and Continued Revenue Growth

Boston Solar Commercial Division Completes Solar Installation for Twin Solar Systems at Framingham, MA Apartment Complex

Events

Keynotes and 50 Companies to Present at the Planet MicroCap Showcase: VANCOUVER in association with Small Cap Discoveries on September 25-26, 2024 at the Fairmont Waterfront Vancouver

Comments

SinglePoint

SinglePoint (SING) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga